Featured Stories

Commentary
Gaining a Better Understanding for Safe Use of Ibrutinib
November 08, 2019
Chris Fausel, PharmD, MHA, BCOP, clinical manager at Indiana University Simon Cancer Center, breaks down practical considerations to ensure the safe use of ibrutinib with regard to concomitant…
Interview
Evolving Treatment for CLL, Small Molecule Inhibitors May Become Standard
November 08, 2019
Robert Greer, RPh, BCOP, senior director of clinical strategy and programs at Magellan Rx Management, discusses the use of ibrutinib compared with…
News
As CKD Progresses, ACE-I/ARB Discontinuation Rates Increase
November 07, 2019
Strong risk factors for ACE-I/ARB discontinuation were hyperkalemia, hypotension, low bicarbonate level, and hospitalization related to acute kidney…
Conference Insider
Value Assessment Framework Effects on Payer Coverage Decisions
November 06, 2019
As value assessment frameworks become more prominent in health care, researchers conducted a survey to see how these tools are impacting payer…
News
Financial Incentives for Cancer Screenings Yield Mixed Results
November 06, 2019
“Ongoing monitoring of incentive programs is critical to determining the effectiveness of financial incentives and their effects on the improvement…
Commentary
Deeper Analysis of the Top Democratic Contenders’ Health Proposals
November 06, 2019
Our expert analysis of the top democratic candidates continues with a look at how skeptics view the various plans and what might happen to a single-…
News
Poor Depression Care After Heart Attack, Stroke Increases Patient Costs
November 06, 2019
Study findings show that 60% of patients receive inadequate care for major depressive disorder following heart attack or stroke, which researchers…
Back to Top